Watson Pushes To Sever Lidoderm, Opana Pay-For-Delay Suits
Watson Laboratories Inc. and its owner, Allergan PLC, on Tuesday again urged a Pennsylvania federal court to sever the Federal Trade Commission's case claiming that Watson delayed generic competition for Lidoderm...To view the full article, register now.
Already a subscriber? Click here to view full article